Physician profile
Mia Talmor
NPI 1780601674
$81,323.17
in general payments reported to CMS, 2019-2025
16 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,488 · 2020: $516 · 2021: $1,635 · 2022: $1,776 · 2023: $408 · 2024: $13K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $43K · Honoraria: $25K · Travel and Lodging: $4,972 · Food and Beverage: $2,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $42,687.50 |
| Honoraria | $25,000.00 |
| Travel and Lodging | $4,972.35 |
| Food and Beverage | $2,248.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $76,581.46 | 2019-2025 | |
| Sientra, INC. | $1,487.69 | 2019-2022 | |
| Integra Lifesciences Corporation | $844.61 | 2021-2022 | |
| Allergan, INC. | $623.31 | 2019-2022 | |
| Mentor Worldwide LLC | $389.17 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Davol INC. | $332.86 | 2019-2024 | Phasix Mesh |
| Kerecis Limited | $142.34 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| W. L. Gore & Associates, INC. | $141.03 | 2019 | |
| Axogen | $125.24 | 2019 | |
| Acell, INC. | $120.27 | 2020 | |
| Becton, Dickinson and Company | $114.86 | 2024 | Phasix Mesh |
| Abbvie INC. | $110.25 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Avita Medical Americas, LLC | $107.97 | 2023 | Recell |
| Coopersurgical, INC. | $100.37 | 2020 | |
| Merz North America, INC. | $71.74 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $30.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mia Talmor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.